BMA follows Lancet in quitting group on collaboration between doctors and drug industry

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1574 (Published 8 March 2013)
Cite this as: BMJ 2013;346:f1574

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Zosia Kmietowicz
  1. 1BMJ

The BMA has become the second organisation in a month to withdraw its support for a document outlining how healthcare professionals and the drug industry could collaborate.

In February, the Lancet said that it no longer backed the four page document,1 which was published in 2012 by the Ethical Standards in Health and Life Sciences Group (ESHLSG). The group is co-chaired by the president of the Royal College of Physicians, Richard Thompson, and the president of the Association of the British Pharmaceutical Industry, Deepak Khanna.2

Richard Horton, editor of the Lancet, said that the …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL